MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 11, 2005; DOI: 10.1124/mol.105.015966


0026-895X/06/6901-278-287$20.00
Mol Pharmacol 69:278-287, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015966v1
69/1/278    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riddall, D. R.
Right arrow Articles by Garthwaite, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riddall, D. R.
Right arrow Articles by Garthwaite, J.

A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain

Dieter R. Riddall, Michael J. Leach, and John Garthwaite

Wolfson Institute for Biomedical Research, University College London, London United Kingdom (D.R.R., J.G.); and School of Science and School of Pharmacy, University of Greenwich at Medway, Chatham Maritime, United Kingdom (M.J.L.)

The effectiveness of several antiepileptic, analgesic, and neuroprotective drugs is attributable to state-dependent inhibition of voltage-gated sodium channels. To help characterize their site and mode of action on sodium channels, a member of the lamotrigine family, R-(-)-2,4-diamino-6-(fluromethyl)-5-(2,3,5-trichlorophenyl)-pyrimidine (BW202W92), was radiolabeled and used as a binding ligand in rat forebrain synaptosomes. Although the level of specific [3H]BW202W92 binding in a standard incubation medium was relatively poor, low concentrations of tetrodotoxin (EC50 = 2-3 nM) greatly enhanced the binding, apparently by increasing the affinity of the binding sites. Tetrodotoxin-dependent binding was stereoselective (the less active enantiomer, S-(-)-2,4-diamino-6-(fluromethyl)-5-(2,3,5-trichlorophenyl)-pyrimidine (BW203W92), was up to 30-fold less potent, depending on conditions) and was extremely sensitive to inhibition by raised K+ concentration (IC50 = 5.9 mM), an effect that was ascribed to changes in membrane potential. In addition, the binding was inhibited by sodium channel neurotoxins acting on sites 3 and 4, but it was resistant to batrachotoxin (site 2) and brevetoxin (site 5). Several drugs acting on sodium channels displaced tetrodotoxin-dependent [3H]BW202W92 binding, and most of those tested showed different affinities under depolarized (100 mM K+) and polarized (1 mM K+) conditions. In a subset of compounds for which data were available, binding affinity in depolarized synaptosomes correlated well with apparent affinity for the inactivated state of sodium channels. The [3H]BW202W92 binding site is novel and is likely to represent a pharmacologically important site of action of drugs on voltage-gated sodium channels in the brain.


Received June 21, 2005; accepted October 11, 2005

Address correspondence to: Dr. John Garthwaite, Wolfson Institute for Biomedical Research, University College London, Gower St., London WC1E 6BT, UK. E-mail: john.garthwaite{at}ucl.ac.uk




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. C. Errington, T. Stohr, C. Heers, and G. Lees
The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels
Mol. Pharmacol., January 1, 2008; 73(1): 157 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Liu, L. Chen, W. Liedtke, and S. A. Simon
Changes in Osmolality Sensitize the Response to Capsaicin in Trigeminal Sensory Neurons
J Neurophysiol, March 1, 2007; 97(3): 2001 - 2015.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics